中文 | English
Return
Total: 354 , 1/36
Show Home Prev Next End page: GO
MeSH:(*Ligands)

1.Combination of a Rapidly Penetrating Agonist and a Slowly Penetrating Antagonist Affords Agonist Action of Limited Duration at the Cellular Level

Larry V PEARCE ; Jihyae ANN ; Peter M BLUMBERG ; Jeewoo LEE

Biomolecules & Therapeutics 2019;27(5):435-441

2.Characteristics in Molecular Vibrational Frequency Patterns between Agonists and Antagonists of Histamine Receptors.

S June OH

Genomics & Informatics 2012;10(2):128-132

3.Systematic Analysis of Translocator Protein 18 kDa (TSPO) Ligands on Toll-like Receptors-mediated Pro-inflammatory Responses in Microglia and Astrocytes.

Ji Won LEE ; Hyeri NAM ; Seong Woon YU

Experimental Neurobiology 2016;25(5):262-268

4.Toll-Like Receptor Ligands as Cancer Immunotherapeutics.

Shee Eun LEE ; Joon Haeng RHEE

Journal of Bacteriology and Virology 2012;42(3):255-262

5.A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention.

Yoo Hyun UM ; Woo Hee CHOI ; Won Sang JUNG ; Young Ha PARK ; Chang Uk LEE ; Hyun Kook LIM

Psychiatry Investigation 2017;14(4):521-524

6.Scintillation Proximity Assay.

Chang Woon CHOI

Korean Journal of Nuclear Medicine 1999;33(6):461-465

7.Massive Identification of Cancer-Specific Nucleic Acid Ligands.

Young Ju LEE ; Seong Wook LEE

Genomics & Informatics 2005;3(2):77-80

8.Bidirectional ephrin signaling in bone.

Charles H RUNDLE ; Weirong XING ; Kin Hing William LAU ; Subburaman MOHAN

Osteoporosis and Sarcopenia 2016;2(2):65-76

9.Progress in study of selective ERβ ligands.

Jin-ya CAI ; Jun-hao LI ; Shi-hui DING ; Juan ZHANG ; Gui-xia LIU ; Wei-hua LI ; Yun TANG

Acta Pharmaceutica Sinica 2015;50(6):658-667

10.Advances of study on PPARgamma/PPARgamma ligand in hematologic malignancies.

Hai-Wen HUANG ; De-Pei WU

Journal of Experimental Hematology 2009;17(6):1592-1596

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 354 , 1/36 Show Home Prev Next End page: GO